|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/553 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3173084 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16201715.6 |
| Europos patento paraiškos padavimo data | 2006-11-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 05110656 | 2005-11-11 | EP |
| (72) |
SOLCA, Flavio, DE
AMELSBERG, Andree, DE
STEHLE, Gerd, DE
VAN MEEL, Jacobus C. A., DE
BAUM, Anke, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim am Rhein, DE |
| (54) | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES |
| QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES |